Albert-Ludwigs-Universität Freiburg

Continued versus interrupted targeted therapy during metastasis‐directed stereotactic radiotherapy: A retrospective multi‐center safety and efficacy analysis (2021) Kroeze SGC, Fritz C, Schaule J, Blanck O, Kahl KH, Kaul D, Siva S, et al. Journal article Roadmap on organic-inorganic hybrid perovskite semiconductors and devices (2021) Schmidt-Mende L, Dyakonov V, Olthof S, Ünlü F, Lê KMT, Mathur S, Karabanov AD, et al. Journal article EARLY CHILDHOOD HEIGHT-ADJUSTED TOTAL KIDNEY VOLUME AS A RISK MARKER OF KIDNEY SURVIVAL IN AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) (2021) Burgmaier K, Kilian S, Arbeiter K, Atmis B, Buescher A, Derichs U, Dursun I, et al. Conference contribution Simulation-based resilience quantification of an indoor ultrasound localization system in the presence of disruptions (2021) Jain AK, Schott DJ, Scheithauer H, Häring I, Höflinger F, Fischer G, Habets E, et al. Journal article A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, De La Rosa K, Tenbusch M, Schulz S, et al. Journal article Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network (2021) Gay F, Guenther A, Offidani M, Engelhardt M, Salvini M, Montefusco V, Patriarca F, et al. Journal article Innovative radiation oncology Together - Precise, Personalized, Human Vision 2030 for radiotherapy & radiation oncology in Germany (2021) Krug D, Hecht M, Ebert N, Maeurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article Value of PET imaging for radiation therapy (2021) Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, et al. Journal article, Review article Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution